Terms: = Brain cancer AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS
329 results:
1. Experience of multi-disciplinary treatment of multiple cerebellar diffuse large B-cell lymphoma: A case report.
Guo Y; Li J; Li M; Li Z; Cui Y; Li Y; Zhao R; Han Q; Yang H; Ma C
Medicine (Baltimore); 2024 Apr; 103(17):e37923. PubMed ID: 38669361
[TBL] [Abstract] [Full Text] [Related]
2. Focused ultrasound-mediated blood-brain barrier opening is safe and feasible with moderately hypofractionated radiotherapy for brainstem diffuse midline glioma.
Tazhibi M; McQuillan N; Wei HJ; Gallitto M; Bendau E; Webster Carrion A; Berg X; Kokossis D; Zhang X; Zhang Z; Jan CI; Mintz A; Gartrell RD; Syed HR; Fonseca A; Pavisic J; Szalontay L; Konofagou EE; Zacharoulis S; Wu CC
J Transl Med; 2024 Mar; 22(1):320. PubMed ID: 38555449
[TBL] [Abstract] [Full Text] [Related]
3. Quality assurance for focused ultrasound-induced blood-brain barrier opening procedure using passive acoustic detection.
Chien CY; Xu L; Yuan J; Fadera S; Stark AH; Athiraman U; Leuthardt EC; Chen H
EBioMedicine; 2024 Apr; 102():105066. PubMed ID: 38531173
[TBL] [Abstract] [Full Text] [Related]
4. fus unveiled in mitochondrial DNA repair and targeted ligase-1 expression rescues repair-defects in fus-linked motor neuron disease.
Kodavati M; Wang H; Guo W; Mitra J; Hegde PM; Provasek V; Rao VHM; Vedula I; Zhang A; Mitra S; Tomkinson AE; Hamilton DJ; Van Den Bosch L; Hegde ML
Nat Commun; 2024 Mar; 15(1):2156. PubMed ID: 38461154
[TBL] [Abstract] [Full Text] [Related]
5. Blood-brain Barrier Disruption for the Treatment of Primary brain Tumors: Advances in the Past Half-Decade.
Virtanen PS; Ortiz KJ; Patel A; Blocher WA; Richardson AM
Curr Oncol Rep; 2024 Mar; 26(3):236-249. PubMed ID: 38329660
[TBL] [Abstract] [Full Text] [Related]
6. Potential prognostic determinants for FET::CREB fusion-positive intracranial mesenchymal tumor.
Mezzacappa FM; Smith FK; Zhang W; Gard A; Cabuk FK; Gonzalez-Gomez I; Monforte HL; Liang J; Singh O; Quezado MM; Aldape KD; Gokden M; Bridge JA; Chen J
Acta Neuropathol Commun; 2024 Jan; 12(1):17. PubMed ID: 38291529
[TBL] [Abstract] [Full Text] [Related]
7. Profiling of Unfolded Protein Response Markers and Effect of IRE1α-specific Inhibitor in Pituitary Neuroendocrine Tumor.
Morita S; Uraki S; Ariyasu H; Tsuji T; Doi A; Furuta H; Yamoto T; Nakao N; Akamizu T; Matsuoka TA
Endocrinology; 2024 Feb; 165(4):. PubMed ID: 38289718
[TBL] [Abstract] [Full Text] [Related]
8. Focused ultrasound-assisted delivery of immunomodulating agents in brain cancer.
Memari E; Khan D; Alkins R; Helfield B
J Control Release; 2024 Mar; 367():283-299. PubMed ID: 38266715
[TBL] [Abstract] [Full Text] [Related]
9. IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma.
Conconi A; Chiappella A; Ferreri AJM; Stathis A; Botto B; Sassone M; Gaidano G; Balzarotti M; Merli F; Tucci A; Vanazzi A; Tani M; Bruna R; Orsucci L; Cabras MG; Celli M; Annibali O; Liberati AM; Zanni M; Ghiggi C; Pisani F; Pinotti G; Dore F; Esposito F; Pirosa MC; Cesaretti M; Bonomini L; Vitolo U; Zucca E
Blood Adv; 2024 Mar; 8(6):1541-1549. PubMed ID: 38181782
[TBL] [Abstract] [Full Text] [Related]
10. Disruption of MAM integrity in mutant fus oligodendroglial progenitors from hiPSCs.
Zhu Y; Burg T; Neyrinck K; Vervliet T; Nami F; Vervoort E; Ahuja K; Sassano ML; Chai YC; Tharkeshwar AK; De Smedt J; Hu H; Bultynck G; Agostinis P; Swinnen JV; Van Den Bosch L; da Costa RFM; Verfaillie C
Acta Neuropathol; 2024 Jan; 147(1):6. PubMed ID: 38170217
[TBL] [Abstract] [Full Text] [Related]
11. Afatinib-Induced Tumor Lysis Syndrome in Pulmonary Adenocarcinoma: A Case Report and Literature Review.
Hong G
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138247
[TBL] [Abstract] [Full Text] [Related]
12. Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study.
Chen KT; Huang CY; Pai PC; Yang WC; Tseng CK; Tsai HC; Li JC; Chuang CC; Hsu PW; Lee CC; Toh CH; Liu HL; Wei KC
J Neurooncol; 2023 Dec; 165(3):535-545. PubMed ID: 38060066
[TBL] [Abstract] [Full Text] [Related]
13. Kinase expression in angiomatoid fibrous histiocytoma: panTRK is commonly expressed in the absence of
Vargas AC; Joy C; Maclean FM; Bonar F; Wong DD; Gill AJ; Cheah AL
J Clin Pathol; 2024 Mar; 77(4):251-254. PubMed ID: 38053271
[TBL] [Abstract] [Full Text] [Related]
14. Targeting diffuse midline gliomas: The promise of focused ultrasound-mediated blood-brain barrier opening.
Martinez PJ; Green AL; Borden MA
J Control Release; 2024 Jan; 365():412-421. PubMed ID: 38000663
[TBL] [Abstract] [Full Text] [Related]
15. Bi-allelic ACBD6 variants lead to a neurodevelopmental syndrome with progressive and complex movement disorders.
Kaiyrzhanov R; Rad A; Lin SJ; Bertoli-Avella A; Kallemeijn WW; Godwin A; Zaki MS; Huang K; Lau T; Petree C; Efthymiou S; Karimiani EG; Hempel M; Normand EA; Rudnik-Schöneborn S; Schatz UA; Baggelaar MP; Ilyas M; Sultan T; Alvi JR; Ganieva M; Fowler B; Aanicai R; Tayfun GA; Al Saman A; Alswaid A; Amiri N; Asilova N; Shotelersuk V; Yeetong P; Azam M; Babaei M; Monajemi GB; Mohammadi P; Samie S; Banu SH; Pinto Basto J; Kortüm F; Bauer M; Bauer P; Beetz C; Garshasbi M; Issa AH; Eyaid W; Ahmed H; Hashemi N; Hassanpour K; Herman I; Ibrohimov S; Abdul-Majeed BA; Imdad M; Isrofilov M; Kaiyal Q; Khan S; Kirmse B; Koster J; Lourenço CM; Mitani T; Moldovan O; Murphy D; Najafi M; Pehlivan D; Rocha ME; Salpietro V; Schmidts M; Shalata A; Mahroum M; Talbeya JK; Taylor RW; Vazquez D; Vetro A; Waterham HR; Zaman M; Schrader TA; Chung WK; Guerrini R; Lupski JR; Gleeson J; Suri M; Jamshidi Y; Bhatia KP; Vona B; Schrader M; Severino M; Guille M; Tate EW; Varshney GK; Houlden H; Maroofian R
Brain; 2024 Apr; 147(4):1436-1456. PubMed ID: 37951597
[TBL] [Abstract] [Full Text] [Related]
16. Human brain mapping using co-registered fus, fMRI and ESM during awake brain surgeries: A proof-of-concept study.
Soloukey S; Collée E; Verhoef L; Satoer DD; Dirven CMF; Bos EM; Schouten JW; Generowicz BS; Mastik F; De Zeeuw CI; Koekkoek SKE; Vincent AJPE; Smits M; Kruizinga P
Neuroimage; 2023 Dec; 283():120435. PubMed ID: 37914090
[TBL] [Abstract] [Full Text] [Related]
17. Focused ultrasound for brain metastases: an update on global clinical trials.
Chen YH; Moore D; Lee CC; Su YH
J Neurooncol; 2023 Oct; 165(1):53-62. PubMed ID: 37910281
[TBL] [Abstract] [Full Text] [Related]
18. Elevated 4R tau contributes to endolysosomal dysfunction and neurodegeneration in VCP-related frontotemporal dementia.
Hung C; Patani R
Brain; 2024 Mar; 147(3):970-979. PubMed ID: 37882537
[TBL] [Abstract] [Full Text] [Related]
19. Integrated analysis of transcriptomic and proteomic alterations in mouse models of ALS/FTD identify early metabolic adaptions with similarities to mitochondrial dysfunction disorders.
Matveeva A; Watters O; Rukhadze A; Khemka N; Gentile D; Perez IF; Llorente-Folch I; Farrell C; Lo Cacciato E; Jackson J; Piazzesi A; Wischhof L; Woods I; Halang L; Hogg M; Muñoz AG; Dillon ET; Matallanas D; Arijs I; Lambrechts D; Bano D; Connolly NMC; Prehn JHM
Amyotroph Lateral Scler Frontotemporal Degener; 2024 Feb; 25(1-2):135-149. PubMed ID: 37779364
[TBL] [Abstract] [Full Text] [Related]
20. Analysis of asymptomatic Drosophila models for ALS and SMA reveals convergent impact on functional protein complexes linked to neuro-muscular degeneration.
Garcia-Vaquero ML; Heim M; Flix B; Pereira M; Palin L; Marques TM; Pinto FR; de Las Rivas J; Voigt A; Besse F; Gama-Carvalho M
BMC Genomics; 2023 Sep; 24(1):576. PubMed ID: 37759179
[TBL] [Abstract] [Full Text] [Related]
[Next]
